ClinConnect ClinConnect Logo
Search / Trial NCT06474130

Assessing Cervical Sensorimotor Control With VR in Chronic Neck Pain

Launched by NATIONAL CHENG KUNG UNIVERSITY · Jun 19, 2024

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

Sensorimotor Control Virtual Reality Chronic Neck Pain Cervical

ClinConnect Summary

This clinical trial is exploring how virtual reality (VR) can be used to assess control of neck movement in people with chronic neck pain (CNP). Researchers want to create a VR system that tests different aspects of neck movement and find out how individuals with CNP perform compared to those without any neck pain. The goal is to improve understanding and treatment for those suffering from neck issues.

To participate in this study, individuals should be between the ages of 18 and 75. Those with chronic neck pain must have experienced pain for at least three months, while healthy adults should not have had any pain or related issues in the last six months. Participants can expect to engage in VR activities that assess neck movement, which could help researchers design better treatment options in the future. It's important to note that some medical conditions and certain lifestyle factors may prevent individuals from joining the trial, such as recent neck injuries, certain diseases, or difficulties with balance.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. For patients with chronic neck pain:
  • Pain was unilateral or bilateral between the superior nuchal line and 1st thoracic vertebra,
  • Neck pain persisting for 3 months and above,
  • Average pain intensity of last pain episode was between 2 and 8 based on the numerical rating scale (NRS)
  • 2. Healthy asymptomatic adults:
  • Do not have any complaints of current pain and impairments of neuromusculoskeletal systems within the last 6 months
  • Exclusion Criteria:
  • acute or the first onset of neck pain
  • previous fracture or surgery of the spine
  • diagnosed cardiopulmonary diseases, for example, chronic obstructive pulmonary disease, pulmonary tuberculosis, asthma, chronic bronchitis, pulmonary emphysema
  • diagnosed gastrointestinal and abdominal conditions which may interfere daily activities within the past 6 months
  • medical conditions that may affect balance and study procedures (e.g. neurological diseases, vestibular disorders, malignant tumors)
  • metabolic diseases such as anemia and diabetes
  • smoking, plan to pregnant or in pregnancy
  • psychological disorders (affect questionnaire responses)
  • unable to walk independently
  • Corrected visual abnormalities or individuals unable to wear contact lenses for vision correction due to the potential interference of wearing VR head-mounted display with glasses

About National Cheng Kung University

National Cheng Kung University (NCKU) is a prestigious research institution located in Tainan, Taiwan, renowned for its commitment to advancing medical science and innovation. With a strong emphasis on interdisciplinary collaboration, NCKU conducts cutting-edge clinical trials aimed at improving healthcare outcomes and addressing critical health challenges. The university leverages its extensive academic resources and state-of-the-art facilities to foster high-quality research and development, ensuring that its clinical trials adhere to rigorous ethical standards and regulatory compliance. NCKU's dedication to education, research, and community service positions it as a leading sponsor in the field of clinical research, contributing significantly to the global medical landscape.

Locations

Tainan, , Taiwan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported